Document is current
Any future updates will be listed below
-
Authors
Saif, Md Saiful Islam
Sehgal, Kartik
Zhang, Ze
Butler, Rondi A.
Wiencke, John K.
Molinaro, Annette M.
Miller, Julianna
Stolrow, Hannah G.
Shirai, Keisuke
Salas, Lucas A.
Koestler, Devin C.
Haddad, Robert
Christensen, Brock C.
Kelsey, Karl T.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA253976)
National Cancer Institute Cancer Center (P30CA168524)
National Cancer Institute Cancer Center (P30CA023108)
NIGMS COBRE (P30GM149408)
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 8 December 2025
First Online: 24 December 2025
Declarations
:
: Drs. Kelsey, Wiencke, Salas, and Christensen are co-founders of Cellintec, which had no role in this research. Dr. Christensen is an advisor to Guardant Health, who had no role in this research. Dr. Sehgal reported receiving consulting fees from Scholar Rock, AmeriSourceBergen, Guidepoint Global, and Equinox Group, Inc.; receiving personal fees for consulting or advisory board participation from Exelexis Inc, Pfizer, and MedScape; receiving research funding to the institution from Merck and Pfizer; and honorarium from Merck, Gilead, Pri-Med and BinayTara Foundation, all were unrelated to this research.
